By 2023, the International Society of Pharmacometrics (ISoP) will be the premier organization advancing the discipline of pharmacometrics throughout the world. ISoP will actively champion the expanding role of pharmacometrics in protecting and improving human health, by:
- Broadening ISoP’s outreach to become a truly international society, increasing membership by 50%, and sponsoring pharmacometrics meetings worldwide.
- Increasing the awareness of key decision-makers, such as regulators, clinicians, payers (anyone setting pricing or reimbursement policies), patient advocates, and industry leadership, to the impact of pharmacometrics on drug discovery, development, and clinical practice.
- Strengthening core pharmacometric capabilities through research support and educational initiatives, while increasing the exposure of society members to new areas, such as health economics and machine learning.
- Improving development of and access to educational resources, pharmacometrics tools, and open-science resources for society members at every stage of their career.
Core Activity Areas
We have identified the following six areas for our core activity under the Five-Year Strategic Plan. Working groups will be established to plan and implement each of these.